Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults

NCT01386164 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT01386164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01386164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults
Lead sponsor
University of Aarhus
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2011
Completion date
August 31, 2013
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, human papillomavirus